1. Repayment in full or in part, of certain of our outstanding borrowings
2. Funding capital expenditure towards purchase of new machinery
3. Funding to meet working capital requirements
4. General Corporate Purpose
...
and Dry Syrups. Our facility has received FDCA License, WHO Certificate, ISO 9001:2015 quality management system certification and ISO 14001:2015 Environment Management System certificationfor manufacturing of General Tablets, Capsules, Oral Liquid, External Preparations and Dry Syrup. During the Fiscal 2025, 2024 and 2023 we derived revenue from sales of 250, 67 and 21 number of pharmaceutical productsWe also undertake contract manufacturing of pharmaceutical products on a loan license basis, wherein our manufacturing facilities are utilized by third-party companies (loan license holders) who possess the necessary marketing authorizations and market the products under their own brand names. This model enables us to optimize our manufacturing capacities and establish long-term business relationships. In addition to contract manufacturing, we also sell our products to third-party distributors and participants in the pharmaceutical market. Under this arrangement, we sell finished goods on a principal-to-principal model. We focus on introducing our products in the emerging markets. Our facility received approval from The Food & Drugs Authority, Ghana and Pharmaceutical Manufacturer Registration License from Kingdom of Cambodia. Furthermore, we have applied for approvals/registration of our facility from the regulatory authorities of Dubai, Iraq and North Sudan. Currently, we export our products largely through local merchant exporters in countries like: Angola, Cameroon, Congo, Fiji, Iraq, Liberia,Myanmar, Guyana, Nigeria, Qatar, Papua new guinea, Sierra Leone, Soloman, Somalia, South sudan UAE, Zambia etc. Read More
Posted on Dec 6th
AAA Technologies informs about change in management
Posted on Dec 5th
Riddhi Display Equipments coming with IPO to raise Rs 24.68 crore
Posted on Dec 5th
Shashi Tharoor slams Opposition over Parliament disruptions
Posted on Dec 5th
Currency futures for December expiry trade weaker with 0.77% increase in OI
An Initial Public Offering (IPO) is when a private company sells shares to the public for the first time, enabling investors to purchase these shares and gain partial ownership in the business. For instance, if a well-known tech firm wants to grow and requires additional funds, it might choose to go public through an IPO. During this process, investors can buy shares, and the company’s stock starts trading on the stock exchange on the day of the IPO listing.
Investors can apply for an IPO through their bank or brokerage account. Many trading platforms have a specific section for IPOs where users can submit their applications online.
The primary market is where shares are offered to the public for the first time via an IPO. After the IPO, shares are traded on the secondary market (stock exchange), where existing shareholders can sell to new buyers.
Investing in an IPO offers the opportunity to become an early investor in companies with high growth potential, at a price which may be lower than their post-listing market value. It provides a chance to participate in the company's growth journey from its early stages. However, IPO investments also come with inherent risks, such as market volatility and uncertainties about the company's future performance.
The price of an IPO is established through a systematic process known as "book building." In this method, investors bid within a given price range, and the final price is set based on demand and market conditions. Several factors play a crucial role in determining the IPO price, including:
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.